“Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults” by Khalid Hussain AL-Qahtani et al.
ORIGINAL RESEARCH ARTICLE Open Access
“Clinicopathological features and treatment
outcomes of differentiated thyroid cancer
in Saudi children and adults”
Khalid Hussain AL-Qahtani1, Mutahir A. Tunio2*, Mushabbab Al Asiri3, Naji J. Aljohani4, Yasser Bayoumi5,
Khalid Riaz2 and Wafa AlShakweer6
Abstract
Introduction: Age is an important prognostic factor in differentiated thyroid cancer (DTC). Our aim was to evaluate
differences in clinicopathological features and treatment outcomes among children and adult patients with DTC.
Materials and methods: We studied 27 children (below 18 years) with DTC treated during the period 2000–2012
and were compared with (a) 78 adults aged 19–25 years and (b) 52 adults aged 26–30 years treated during the
same period in terms of their clinicopathological features and long term treatment outcomes. Locoregional
recurrence (LRR), locoregional control (LRC), distant metastasis (DM), distant metastasis control (DMC), disease free
survival (DFS) and overall survival (OS) rates were evaluated.
Results: Mean age of children was 13.5 years (range: 5–18), while mean age of adults was 24.6 years (range: 19–30). In
children, female: male ratio was 2.85:1, and in adults female: male ratio was 7.1:1 (P = 0.041). No significant difference in
tumor size was seen between the two groups (P = 0.653). According to American Thyroid Association (ATA) risk
stratification classification, the children (85.2 %) were found to have at high risk as compared to adults P = 0.001.
Post-thyroidectomy complications and RAI induced toxicities were observed more in children than adults (P = 0.043
and P = 0.041 respectively). LRR occurred in 6 (22.2 %), 9 (11.5 %) and 3 (5.8 %) in age groups of <18 years, 19–25 years
and 26–30 years respectively (P = 0.032); while DM was seen in 10 (37.0 %), 9 (10.3 %) and 5 (9.6 %) in age groups
of <18 years, 19–25 years and 26–30 years respectively (P = 0.002). Ten year DFS rates were 67.3 % in age group
below 18 years, 82.4 % in age group of 19–25 years and 90.1 % in age group of 26–30 years (P = 0.021).
Conclusion: At the time of diagnosis, children with DTC were found to have more aggressive clinicopathological
characteristics. Comparatively lower LRC, DMC and DFS rates in children warrants further multi-institutional studies.
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Background
The incidence of differentiated thyroid cancers (DTC),
including papillary (PTC) and follicular (FTC) variants,
is increasing exponentially over the past years through-
out the world with a wide geographic variation [1]. In
Kingdom of Saudi Arabia, DTC is the second most com-
mon malignancy among middle aged women [2]. DTC is
relatively uncommon in children (age 18 years or below),
adolescents (under 25 years old), and young adults
(above 25 and below 30 years) accounting for 3–10 %.
Recent data has suggested that the frequency of DTC in
children varies according to pre-puberty, puberty and
adolescence growth phases [3, 4]. In contrast to adults,
DTC in pre-pubertal children has some distinctive dif-
ferences; such as (a) larger primary tumor at the time of
diagnosis; (b) high prevalence of neck lymph nodes and
distant metastases at the time of diagnosis; and (c) the
high risk of recurrences [5].
DTC in children and adolescents is treated in similar
fashion as that in adults, primarily because of rarity of
disease in pediatric population and lack of availability of
pediatric DTC treatment guidelines [6]. Fortunately,
even with aggressive behavior, DTC in children has
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excellent prospects with use of thyroidectomy, neck dis-
section, radioactive iodine-131 (RAI) ablation and sup-
pression of thyroid-stimulating hormone (TSH) secretion
with levothyroxine [5, 6].
In the current study, we designed our approach towards
the comparative analysis of different clinicopathological
features and treatment outcomes among children, adoles-
cents and young adults with DTC in Kingdom of Saudi
Arabia.
Methods
After formal approval from the institutional ethical
committee, medical records of 157 DTC patients of age
less than 30 years, who were treated at our hospital
during the period of July 2000 and December 2012
were reviewed using computer based database system.
For the purpose of present study, the study population
was divided in three groups; (a) children (patients below
or equal to the age of 18 years), (b) young adults (aged
19 to 25 years) and (c) adults (aged 26 to < 30 years) [7].
Demographic, clinicopathological and radiological data
Demographic and clinical data including age at the time
of diagnosis, gender and symptomatology were reviewed.
A detailed second review of all histopathological speci-
mens was done by experienced histopathologist. Differ-
ent histopathological characteristics, including tumor
size, histopathologic variants, multifocality, tumor, lymph
node and metastasis (TNM) staging were recorded. Data
was collected from different imaging modalities including
neck ultrasonography (USG), whole body I-131 scintig-
raphy (WBS), computed tomography (CT) scan of neck
and chest and flourodeoxyglucose positron emission tom-
ography (FDG-PET). Data regarding different treatment
modalities including thyroidectomy, +/− neck dissection,
adjuvant radioactive iodine-131 (RAI) ablation and its
doses in millicurie (mCi) were also recorded.
Statistical analysis
The primary endpoint was the disease free survival
(DFS). Secondary points were; the comparative analysis
of different clinicopathological features of DTC in chil-
dren and adults, locoregional control (LRC), distant me-
tastasis control (DMC) and overall survival (OS) rates.
Local recurrence (LR) was defined as the duration
between surgery date and date of clinically or radio-
logically detectable disease in the thyroid bed and/or in
cervical lymph nodes on imaging (USG, WBS, CT and
FDG-PET) after evaluation of elevated thyroglobulin
(TG) levels. Distant metastasis (DM) was defined as
the duration between surgery date and date of docu-
mented disease outside the neck on imaging after
evaluating for elevated TG. DFS was defined as the
duration between surgery date and date of documented
disease reappearance/relapse, death from cancer and/or
last follow-up. OS was defined as the duration between
surgery date and date of patient death or last follow-
up.
Chi-square or Student’s t-tests were used to determine
the differences in various clinical variables. Probabilities
of LRC, DMC, DFS and OS rates were shown with the
Kaplan-Meier method and the comparison for various
survival curves was performed using log rank. All statis-
tical analyses were performed using the computer pro-
gram SPSS version 16.0.
Results
Demographic and clinicopathological features of cohort
The mean age at the time diagnosis of whole cohort was
22.7 years (range: 5–30). The whole cohort (n = 157) was
consisted of 134 (85.4 %) females and 23 (14.6 %) males.
Male gender was predominant in children (25.9 %) than
that in groups 19–25 years (10.3 %) and 26–30 years
(15.4 %) respectively P = 0.038. The predominant histo-
pathology was PTC (95.5 %) whereas FTC was seen only
in 4.5 % of patients. Mean tumor size was 2.9 cm (range:
0.4–6.5) without any statistically significant difference
between the children and adults (P = 0.653). In contrast
to adults, positive lymph nodes were more evident in the
children (74.1 %), P = 0.012. According to ATA risk
stratification classification, the children (85.2 %) were
found to be at higher risk as compared to other age
groups P = 0.003. The clinicopathological and treatment
characteristics are described in Table 1.
All patients underwent total or near total thyroidec-
tomy without any difference between children and
adults. However, because of palpable or radiological vis-
ible lymph nodes, the neck dissection was attempted
more in children than those in other age groups (88.9 %
vs. 67.9 % vs. 71.2 %) P = 0.047. Among 157 patients,
147 (93.6 %) patients were given adjuvant RAI ablation.
Median time to RAI ablation was 8.2 weeks (6.8–16.6)
from thyroidectomy and no significant differences in the
frequency of adjuvant RAI ablation were observed be-
tween the children and adults (P =0.460).
Complications and Toxicities
Post-thyroidectomy complication rates were minimal;
however, permanent hypocalcemia was statistically and
significantly high in children and young adults (P = 0.043).
Overall, RAI ablation was tolerated well without any grade
3 or 4 side effects; however, acute and late (any grade)
complications were seen significantly higher in children
and young adults (P = 0.041) Table 2.
Treatment outcomes
Median follow-up period was 6.2 years (range: 2.0–10).
For whole cohort, the 10-year LRC and DMC rates were
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Table 1 Comaprison of clinicopathological and treatment characteristics of children and adult patients with differentiated thyroid
carcinoma at presentation
Variables Children with DTC
(<18 years)






(n =27) (n =78) (n =52)
Age (years)
Mean/range/SD 13.5 (5–18) ± 4.3 22.41 ± 3.3 27.5 ± 2.8 0.0001
<10 years 8 (29.6) 0 0
11–18 years 19 (70.4) 0 0
Gender, n (%)
M 7 (25.9) 8 (10.3) 8 (15.4) 0.038
F 20 (74.1) 70 (89.7) 44 (84.6) 0.160
Tumor size (cm)
Mean/range/SD 2.8 (0.8–6.5) ± 1.36 2.8 (0.8–6.4) ±1.36 2.9 (0.4–6.5) ±1.62 0.653
Histology n (%)
Papillary 27 (100) 72 (92.3) 51 (98.1) 0.605
Follicular 0 6 (7.7) 1 (1.9)
T stage, n (%)
T1 12 (44.4) 27 (34.6) 26 (50.0) 0.860
T2 11 (40.8) 34 (43.6) 15 (28.9)
T3 4 (14.8) 15 (19.2) 10 (19.2)
T4 0 2 (2.6) 1 (1.9)
N stage, n (%)
N0 7 (25.9) 42 (53.8) 32 (61.5) 0.012
N1 20 (74.1) 36 (46.2) 20 (38.5)
N1a 9 (45.0) 22 (61.1) 11 (55.0)
N1b 11 (55.0) 14 (38.9) 9 (45.0)
M stage, n (%)
M0 26 (96.3) 77 (98.7) 52 (100) 0.379
M1 1 (3.7) 1 (1.3) 0
LVSI, n (%)
Yes 12 (44.4) 27 (34.6) 16 (30.7) 0.031
No 15 (55.6) 51 (65.4) 36 (69.3)
Multifocality, n (%)
Yes 9 (33.3) 43 (55.2) 32 (61.5) 0.012
No 18 (66.6) 35 (44.8) 20 (38.5)
Risk stratification, n (%)
Low 2 (7.4) 17 (21.8) 11 (21.1) 0.003
Intermediate 2 (7.4) 23 (29.5) 21 (40.4)
High 23 (85.2) 38 (48.7) 20 (38.5)
Surgery, n (%)
Total thyroidectomy 23 (85.2) 68 (87.2) 44 (84.6) 0.065
Near total thyroidectomy 4 (14.8) 10 (12.8) 8 (15.4)
Neck dissection, n (%)
No 3 (11.1) 25 (32.1) 15 (28.8) 0.047
Yes 24 (88.9) 53 (67.9) 37 (71.2)
Central 13 (54.2) 30 (56.6) 18 (48.6)
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87.2 and 84.2 % respectively. The 10-year LRC and
DMC rates were significantly lower in children (75.3 and
64.7 % respectively) than those young adults and adults.
Total 18 LRs (11.5 %) were observed; 6/27 in children,
9/78 in young adults and 3/52 in adults (P = 0.032)
Table 3. The LRs were salvaged by surgery; lateral neck
dissection (13 patients); completion thyroidectomy (4
patients) and excision (2 patients) followed by RAI abla-
tion (16 patients). Similarly, total 24 DM (15.3 %) were ob-
served; 10/27 in children, 9/78 in young adults and 5/52
in adults (P = 0.002). DMs were salvaged by RAI ablation
and palliative irradiation for bony lesion (one patient).
The 10-year DFS rates were 67.3 % in children, 82.4 %
in young adults and 90.1 % in adults (p = 0.021) Fig. 1.
There was no statistically significant difference in 10-
year OS rates among all age groups (P = 0.075).
Discussion
Due to rarity of DTC in children and young adults, few
major controversies regarding aggressiveness of clinical
behavior and optimal treatment still persist [8]. In
present study, some unusual observations related to
histopathological features were observed, which are in
contradiction to reported literature.
Firstly, no statistically significant difference in primary
tumor volumes or presence of extrathyroidal extension
(ETE) was observed between the children and adults. Pre-
vious studies have hypothesized that the tumor volumes
Table 1 Comaprison of clinicopathological and treatment characteristics of children and adult patients with differentiated thyroid
carcinoma at presentation (Continued)
Lateral 11 (45.8) 23 (43.4) 19 (51.4)
Adjuvant RAI therapy, n (%)
No 1 (3.7) 7 (9.0) 2 (3.8) 0.460
Yes 26 (96.3) 71 (91.0) 50 (96.2)
30 mCi 0 4 (5.6) 1 (2.0)
100 mCi 7 (27.0) 20 (28.2) 19 (38.0)
150 mCi 14 (53.8) 36 (50.7) 20 (40.0)
200 mCi 5 (19.2) 11 (15.5) 10 (20.0)
N number, DTC differentiated thyroid cancers, SD standrad deviation, M male, F female, T tumor, N node, M metastasis, LVSI lymphovascular space invasion, RAI
radioactive iodine, mCi millicurie
Table 2 Comparative analysis of complications of surgery and toxicities of radioactive iodine ablation in our cohort
Toxicity Children Age below 18 years Young adults Age 19–25 years Adults Age26-30 years P
value(n = 27) (n =78) (n =52)
Thyroidectomy, n (%)
Hypocalcemia 5 (18.5) 11 (14.1) 8 (15.4) 0.064
Transient 4 (80.0) 9 (81.8) 7 (87.5)
Permanent 1 (20.0) 2 (18.2) 1 (12.5) 0.043
Recurrent laryngeal nerve damage 1 (3.7) 1 (1.3) 1 (1.9) 0.072
RAI ablation, n (%)
Acute: 16 (59.3) 36 (46.1) 18 (34.6) 0.041
Sialadenitis 5 (31.3) 12 (33.3) 6 (33.3) 0.071
Acute sickness (nausea, vomiting) 4 (25.0) 17 (47.2) 10 (55.5) 0.042
Neck pain 7 (43.7) 7 (19.5) 2 (11.1) 0.001
RAI ablation, n (%)
Late: 2 (7.4) 3 (3.8) 1 (1.9) 0.034
Sicca syndrome 1 (50.0) 3 (100) 0
Nasolacrimal duct obstruction 1 (50.0) 0 1 (100)
Second malignancy 0 0 0
Infertility 0 0 0
Lung fibrosis 0 0 0
RAI Radioactive iodine, n number
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tend to be relatively larger in children when compared to
adults, probably attributed to smaller thyroid volume in
children, thus higher chances of ETE and capsular inva-
sion [3–5, 9, 10]. Similar to our results, few studies have
also reported no correlation between tumor volumes and
pediatric population [11–13]. However, no difference in
tumor volumes or ETE among children and adults can be
criticized for relatively few pre-pubertal children in our
cohort. Secondly, in contrast to children, multifocality was
found more prevalent in our adult cohort, which is a rea-
sonable argument against wide practice of total thyroidec-
tomy as primary surgical approach in children [14, 15]
Thirdly, male gender was predominant in our pediatric
cohort, which is likely attributed to hormonal changes
during pre-puberty and puberty [16].
Further, it was also clear that larger percentage of chil-
dren underwent elective neck dissections mainly because
of increased frequency of clinical or radiological cervical
lymphadenopathy at the time of diagnosis. Similarly,
treatment related complications were observed more in
children. Large percentage of permanent hypocalcemia
supports the notion of less aggressive surgery (lobec-
tomy or hemi-thyroidectomy) for primary tumor in
children, to decrease the risk of surgical complications
[17, 18]. Similarly, the children experienced relatively
more acute and late (any grade) RAI induced complica-
tions in our cohort. However, no RAI ablation induced
second primary malignancy (SPM), lung fibrosis or in-
fertility was observed. Possible explanation could be the
short follow-up, and given lower cumulative doses of
RAI in our cohort [5, 19].
In contrast to previously published data, children in
our cohort experienced relatively higher all-sites recur-
rence rates, thus lower 10-year DFS rate (67.3 %) after
extensive treatment [4, 5, 7, 9, 20, 21] which is attributed
to our ATA high risk (85.2 %) pediatric cohort.
There were few limitations of our study. Firstly, since
more children were rendered to neck dissections, there
was a possible selection bias when it came to the num-
ber of lymph nodes found to harbor metastasis. Sec-
ondly, TSH suppression therapy complications including
effects on child growth, osteoporosis and cardiovascular
diseases were not studied, as children are still in growing
phase, and TSH suppression therapy theoretically may
affect their final height [22]. Thirdly, we did not look into
molecular patterns in childhood DTC. Bongarzone I et al.
initially reported that the frequency of ‘Rearranged during
Transcription’ (RET) and ‘neurotrophic tyrosine kinase
receptor-1’ (NTRK1) oncogenic activation is significantly
higher in childhood DTC, thus contributing to childhood
DTC carcinogenesis [23]. Besides RET/NTRK1, over-
expression of proto-oncogenes ‘MET’, and ‘vascular endo-
thelial growth factor’ (VEGF) have been found to cause
high recurrence rate in children [24].
Table 3 Pattern of failure after thyroidectomy and radioactive iodine therapy in children and adults with differentiated thyroid
cancer
Failures Children Age below 18 years (n = 27) Young adults Age 19–25 years (n = 78) Adults Age 26–30 years (n =52) P value
Locoregional, n (%) 6 (22.2) 9 (11.5) 3 (5.8) 0.032
Thyroid bed 1 (16.7) 2 (22.2) 0
Lymph nodes 5 (83.3) 7 (77.8) 3 (100)
Distant, n (%) 10 (37.0) 9 (10.3) 5 (9.6) 0.002
Lungs 10 (100) 9 (100) 4 (80.0)
Bones - - 1 (20.0)
Locoregional + distant 4 (14.8) 4 (5.1) 2 (3.8) 0.035
10 year LRC rate 75.3% 87.3 % 93.2 % 0.001
10 year DMC rate 64.7 % 84.8 % 94.2 % 0.0001
10 year OS rate 92.3 % 96.2 % 100 % 0.079
n number, LRC locoregional control, DMC distant metastasis control, OS overall survival
Figure. 1 Kaplan-Meier curves of disease free survival in age groups
< 18 years, 19–25 years and 26–30 years
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Conclusions
In conclusion, DTC in Saudi children is far more aggres-
sive entity in nature as compared to adults. Children are
at higher risk of treatment (thyroidectomy and RAI) re-
lated complications as compared to adults. Lower LRC,
DMC and DFS rates in children after extensive therapy
of thyroidectomy, neck dissection followed by RAI, TSH
suppression warrants further multi-institutional studies.
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